유방 고정술 시장 - 예측(2024-2029년)

The mastopexy market is expected to grow at a CAGR of 6.60% from US$1.466 billion in 2022 to US$2.293 billion in 2029.

A mastopexy with breast augmentation, also known as a breast lift with implants, is a cosmetic surgery technique used to elevate and contour sagging breasts, increase breast fullness, realign drooping nipples, and enhance breast symmetry.

To augment the volume of the breast, the treatment may employ a breast implant. An implant alone can create a rejuvenated look with only a little skin incision when there is modest breast drooping. However, any incision can leave behind permanent scars. The surgery can give the breasts a younger-looking form again.

Market Drivers:

• Opportunities for the mastopexy market to increase as women require better visual appeal.

The mastopexy market growth is due to women's increasing desire for better visual appeal. To improve surgeries and maximize consumer happiness, the major mastopexy industry participants have implemented cutting-edge equipment.

Additionally, the demand for cosmetic breast augmentation treatments is being increased by the rise in medical tourism to several nations, like Thailand, Malaysia, and Mexico.

• The increasing female geriatric population drives the market's growth.

The main factors for the mastopexy market growth over the forecast period are the rise in the number of elderly women and their rising desire for cosmetic operations. According to the United Census Bureau, the number of elderly women worldwide is predicted to increase from 3,601 million in 2015 to 4,139 million by 2030.

One of the numerous advantages of getting breast augmentation surgery is that it improves one's self-esteem and perception of their body. In addition, women over 40 are more likely to lose volume in their breasts and have a lot of extra skin on them as a result of delivery or weight loss. This rising tendency is also influenced by the fact that older women tend to be more financially secure than many younger women.

• The increasing need for full mastopexy is another factor that drives the market.

In terms of revenue, the full mastopexy method is anticipated to command the majority of the mastopexy market. When breast sagging occurs in elderly women, the full mastopexy operation is used. The doctors often remove malignant tissues during the treatment, which may necessitate breast reconstruction surgery.

The Benelli-lollipop lift is also predicted to see significant growth. Vertical lift and vertical mastopexy are other names for it. Incisions made vertically are very useful for removing extra skin that hangs down to the sides of the nipple. The areolas can be reshaped with this method. To create a more symmetrical contour, this technique reshapes and tightens the natural tissue that is already there.

• The surge in medical tourism propels the market to grow.

One of the elements fueling the mastopexy market growth is the rise in medical tourism. The price of medical care is astronomical in wealthy nations. Although the procedures are regarded to be expensive, the therapies are thought to be of a high calibre. The cost of essential healthcare products is also rather high. People who cannot afford to stand in queue for treatment in their native country now have a method to avoid them by seeking care overseas. As a result, to save time and avoid making their medical conditions worse, many people rely on medical tourism and fly abroad to countries that provide immediate operations. Strong government support is thus anticipated to encourage mastopexy market growth.

• Technological advancements in the mastopexy market are also a factor.

Research and development in the biological sciences are increasingly using AI and ML technology. They support the development of novel drugs, improve clinical trials, analyze enormous volumes of biological data, and find patterns that might help us better understand illnesses and create new treatments. In particular, telemedicine, wearable technology, and mobile health apps have all experienced tremendous growth in digital health technologies. These innovations make it possible to monitor patients remotely, improve access to healthcare, and give people greater control over how they manage their health which will upsurge the mastopexy market growth.

• Increasing mastopexy procedures in hospitals makes it popular.

The mastopexy industry's largest revenue generator is anticipated to be the hospitals. The demand for hospitals to provide healthcare services to patients is rising along with the demand for breast surgery for breast augmentation and uplift, which supports the expansion of the mastopexy market.

For instance, the Aesthetic Society reported a 48% increase in breast treatments such as breast augmentation, breast lifts (mastopexies), breast reductions, and combinations of the three. For instance, in 2021, 365,000 breast augmentations were carried out. Facelifts and other specialized operations for the face saw a 54% increase.

The North American patient portal market is projected to propel

North America is predicted to have the largest market share during the forecast period. One of the most popular cosmetic surgery treatments in the area is breast augmentation. The most common reconstructive surgeries each year have been those to remove tumors, including those to remove skin and breast cancer among others.

Furthermore, Asia Pacific is anticipated to hold a significant market share due to rising healthcare costs per capita and rising aesthetic standards. Rising women's health awareness, expanding healthcare infrastructure, and shifting lifestyle trends are some of the major factors influencing the mastopexy industry development in the region. Additionally, the existence of nations with economies like China and Korea where the prevalence of cosmetic procedures is on the rise stimulates mastopexy market development.

Growing prevalence of breast cancer in North American region

The United States is anticipated to continue to provide the largest share of mastopexy market revenue throughout the forecast period. According to statistics from the American Society of Plastic Surgeons, inventive and novel methods of body shaping have been created, and the number of minimally invasive cosmetic procedures has increased by over 200 percent since 2000.

One of the most common cancers in the US is breast cancer. In 2022, Breastcancer.org estimated that 1 in 8 women (or around 13%) may get invasive breast cancer in their lifetime which will upsurge the mastopexy industry in the country.

Market Key Developments:

• In January 2023, The Marena Group, a pioneer in the design and production of shapewear and post-surgery compression apparel, introduced a ground-breaking new technology that can significantly improve the patient's recovery from surgical breast treatments.
• In June 2022, CollPlant announced the beginning of research in big animals for its 3D bioprinted regenerative breast implant program.
• In May 2022, GC Aesthetics introduced the ground-breaking Nipple Areola Complex (NAC) reconstructive implant. The clinical requirements of women all over the world were addressed by this medical equipment.

Segmentation:

By Technique

• Crescent Breast Lift
• Benelli Lift
• Benelli-Lollipop Lift
• Full Mastopexy

By Tissue Incision

• Skin
• Adipose
• Glandular

By End-User

• Hospitals
• Clinics
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline
• 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. MASTOPEXY MARKET, BY TECHNIQUE

• 5.1. Introduction
• 5.2. Crescent Breast Lift
  • 5.2.1. Market Trends and Opportunities
  • 5.2.2. Growth Prospects
  • 5.2.3. Geographic Lucrativeness
• 5.3. Benelli Lift
  • 5.3.1. Market Trends and Opportunities
  • 5.3.2. Growth Prospects
  • 5.3.3. Geographic Lucrativeness
• 5.4. Benelli Lollipop Lift
  • 5.4.1. Market Trends and Opportunities
  • 5.4.2. Growth Prospects
  • 5.4.3. Geographic Lucrativeness
• 5.5. Full Mastopexy
  • 5.5.1. Market Trends and Opportunities
  • 5.5.2. Growth Prospects
  • 5.5.3. Geographic Lucrativeness

6. MASTOPEXY MARKET, BY TISSUE INCISION

• 6.1. Introduction
• 6.2. Skin
  • 6.2.1. Market Trends and Opportunities
  • 6.2.2. Growth Prospects
  • 6.2.3. Geographic Lucrativeness
• 6.3. Adipose
  • 6.3.1. Market Trends and Opportunities
  • 6.3.2. Growth Prospects
  • 6.3.3. Geographic Lucrativeness
• 6.4. Glandular
  • 6.4.1. Market Trends and Opportunities
  • 6.4.2. Growth Prospects
  • 6.4.3. Geographic Lucrativeness

7. MASTOPEXY MARKET, BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
  • 7.2.1. Market Trends and Opportunities
  • 7.2.2. Growth Prospects
  • 7.2.3. Geographic Lucrativeness
• 7.3. Clinics
  • 7.3.1. Market Trends and Opportunities
  • 7.3.2. Growth Prospects
  • 7.3.3. Geographic Lucrativeness
• 7.4. Others
  • 7.4.1. Market Trends and Opportunities
  • 7.4.2. Growth Prospects
  • 7.4.3. Geographic Lucrativeness

8. MASTOPEXY MARKET, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Technique
  • 8.2.2. By Tissue Incision
  • 8.2.3. By End-user
  • 8.2.4. By Country
    • 8.2.4.1. United States
      • 8.2.4.1.1. Market Trends and Opportunities
      • 8.2.4.1.2. Growth Prospects
    • 8.2.4.2. Canada
      • 8.2.4.2.1. Market Trends and Opportunities
      • 8.2.4.2.2. Growth Prospects
    • 8.2.4.3. Mexico
      • 8.2.4.3.1. Market Trends and Opportunities
      • 8.2.4.3.2. Growth Prospects
• 8.3. South America
  • 8.3.1. By Technique
  • 8.3.2. By Tissue Incision
  • 8.3.3. By End-user
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
      • 8.3.4.1.1. Market Trends and Opportunities
      • 8.3.4.1.2. Growth Prospects
    • 8.3.4.2. Argentina
      • 8.3.4.2.1. Market Trends and Opportunities
      • 8.3.4.2.2. Growth Prospects
    • 8.3.4.3. Others
      • 8.3.4.3.1. Market Trends and Opportunities
      • 8.3.4.3.2. Growth Prospects
• 8.4. Europe
  • 8.4.1. By Technique
  • 8.4.2. By Tissue Incision
  • 8.4.3. By End-user
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
      • 8.4.4.1.1. Market Trends and Opportunities
      • 8.4.4.1.2. Growth Prospects
    • 8.4.4.2. Germany
      • 8.4.4.2.1. Market Trends and Opportunities
      • 8.4.4.2.2. Growth Prospects
    • 8.4.4.3. France
      • 8.4.4.3.1. Market Trends and Opportunities
      • 8.4.4.3.2. Growth Prospects
    • 8.4.4.4. Spain
      • 8.4.4.4.1. Market Trends and Opportunities
      • 8.4.4.4.2. Growth Prospects
    • 8.4.4.5. Others
      • 8.4.4.5.1. Market Trends and Opportunities
      • 8.4.4.5.2. Growth Prospects
• 8.5. Middle East and Africa
  • 8.5.1. By Technique
  • 8.5.2. By Tissue Incision
  • 8.5.3. By End-user
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
      • 8.5.4.1.1. Market Trends and Opportunities
      • 8.5.4.1.2. Growth Prospects
    • 8.5.4.2. UAE
      • 8.5.4.2.1. Market Trends and Opportunities
      • 8.5.4.2.2. Growth Prospects
    • 8.5.4.3. Israel
      • 8.5.4.3.1. Market Trends and Opportunities
      • 8.5.4.3.2. Growth Prospects
    • 8.5.4.4. Others
      • 8.5.4.4.1. Market Trends and Opportunities
      • 8.5.4.4.2. Growth Prospects
• 8.6. Asia Pacific
  • 8.6.1. By Technique
  • 8.6.2. By Tissue Incision
  • 8.6.3. By End-user
  • 8.6.4. By Country
    • 8.6.4.1. Japan
      • 8.6.4.1.1. Market Trends and Opportunities
      • 8.6.4.1.2. Growth Prospects
    • 8.6.4.2. China
      • 8.6.4.2.1. Market Trends and Opportunities
      • 8.6.4.2.2. Growth Prospects
    • 8.6.4.3. India
      • 8.6.4.3.1. Market Trends and Opportunities
      • 8.6.4.3.2. Growth Prospects
    • 8.6.4.4. South Korea
      • 8.6.4.4.1. Market Trends and Opportunities
      • 8.6.4.4.2. Growth Prospects
    • 8.6.4.5. Indonesia
      • 8.6.4.5.1. Market Trends and Opportunities
      • 8.6.4.5.2. Growth Prospects
    • 8.6.4.6. Thailand
      • 8.6.4.6.1. Market Trends and Opportunities
      • 8.6.4.6.2. Growth Prospects
    • 8.6.4.7. Others
      • 8.6.4.7.1. Market Trends and Opportunities
      • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. The Esthetic Clinics
• 10.2. Aurora Clinics
• 10.3. Mayo Clinic
• 10.4. Spire Healthcare
• 10.5. Bupa
• 10.6. The Karri Clinic
• 10.7. Pristyn Care
• 10.8. Ramsay Health Care
• 10.9. Aprassa
• 10.10. Rebecca Ayers